Report cover image

Cell Freezing Media Market Size, Share & Trends Analysis Report By Product (DMSO, Glycerol), By Type (Slow Freezing, Vitrification), By Cell Culture Type (2D Cell Culture, 3D Cell Culture), By Application, By End Use, By Region, And Segment Forecasts, 202

Publisher Grand View Research
Published Dec 18, 2025
Length 150 Pages
SKU # GV20723853

Description

Cell Freezing Media Market Summary

The global cell freezing media market size was estimated at USD 1.23 billion in 2025 and is projected to reach USD 2.37 billion by 2033, growing at a CAGR of 9.0% from 2026 to 2033. The market's growth can be attributed to increasing adoption of cell freezing media as an alternative to in-house freezing preparations and the benefits of ready-to-use cryo-preservative media over conventional freezing techniques.

Moreover, rising demand for effective freezing media across a wide range of end-users and various new products launched by key market players are anticipated to fuel market growth.

Global Cell Freezing Media Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global cell freezing media market based on product, type, cell culture type, application, end use, and region.
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • DMSO
  • With Serum
  • Without Serum
  • Glycerol
  • With Serum
  • Without Serum
  • Others
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Slow Freezing
  • Vitrification
  • Cell Culture Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Suspension Cell Culture
  • 2D Cell Culture
  • 3D Cell Culture
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Stem Cells
  • Mesenchymal Stem Cells (MSCs)
  • Hematopoietic Stem Cells (HSCs)
  • Induced Pluripotent Stem Cells (iPSCs)
  • Embryonic Stem Cells (ESCs)
  • Others
  • Cancer Cell Lines
  • Reproductive Cells
  • Primary Cells
  • Bioproduction Cell Lines
  • CHO Cells
  • HEK293 Cells
  • BHK
  • Others
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceuticals and Biotechnology Companies
  • Academic and Research Institutes
  • Biobanks
  • Stem Cells
  • Reproductive Cells
  • Other Cells
  • IVF Clinics
  • Other End Use
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

150 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Software Type
1.2.2. Deployment Mode
1.2.3. Application
1.2.4. End use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing organ transplant volumes and demand
3.2.1.2. Growing prevalence of end-stage organ diseases
3.2.1.3. Regulatory requirements for standardized data reporting and registry submission
3.2.1.4. Need for faster, more accurate donor-recipient matching
3.2.2. Market Restraint Analysis
3.2.2.1. High implementation and maintenance costs of advanced software platforms.
3.2.2.2. Limited IT infrastructure and digital readiness in smaller hospitals or OPOs.
3.2.3. Industry Opportunity Analysis
3.2.4. Industry Challenge Analysis
3.2.5. Technology Overview
3.2.6. Regulatory Overview
3.3. Business Environment Analysis
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal Landscape
Chapter 4. U.S. Organ Donation and Transplant Software Market: Software Type Estimates & Trend Analysis
4.1. Solution Segment Dashboard
4.2. Solution Market Share Movement Analysis, 2025 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by Solution, 2021 to 2033 (USD Million)
4.4. Organ Donor Management Systems
4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Transplant Management Systems
4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Organ Allocation & Matching Platforms
4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Organ Procurement & Logistics Software
4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.8. Others (Registry & Data Management System, etc.)
4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Organ Donation and Transplant Software Market: Deployment Mode Estimates & Trend Analysis
5.1. Deployment Mode Segment Dashboard
5.2. Deployment Mode Market Share Movement Analysis, 2025 & 2033
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
5.4. Cloud-based
5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. On-premise
5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Organ Donation and Transplant Software Market: Application Estimates & Trend Analysis
6.1. Application Segment Dashboard
6.2. Application Market Share Movement Analysis, 2025 & 2033
6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Organ Donation Workflow Automation
6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Waitlist & Recipient Management
6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Transplant Coordination & Scheduling
6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Regulatory Reporting & Compliance
6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Outcome & Data Analytics
6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Healthcare Organ Donation and Transplant Software Market: End Use Estimates & Trend Analysis
7.1. End use Segment Dashboard
7.2. End use Market Share Movement Analysis, 2025 & 2033
7.3. Market Size & Forecasts and Trend Analysis, by End use, 2021 to 2033 (USD Million)
7.4. Hospitals & Transplant Centers
7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Organ Procurement Organizations (OPOs)
7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. National/Regional Health Agencies
7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Research & Academic Institutes
7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Market Position Analysis
8.2. Company Categorization
8.3. Company Profiles/Listing
8.3.1. InVita Healthcare Technologies
8.3.1.1. Participant Overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. XVIVO
8.3.2.1. Participant Overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. CareDx
8.3.3.1. Participant Overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Afflo
8.3.4.1. Participant Overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Ataims Tech
8.3.5.1. Participant Overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. MedSleuth, Inc.
8.3.6.1. Participant Overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. EDITLife
8.3.7.1. Participant Overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Buckeye Transplant Solutions
8.3.8.1. Participant Overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. United Network for Organ Sharing
8.3.9.1. Participant Overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us